Compositions and methods for the treatment of bowel diseases with granulated mesalamine

Details for Australian Patent Application No. 2009298139 (hide)

Owner Dr. Falk Pharma GmbH

Inventors Forbes, William

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2009298139

PCT Pub. Number WO2010/040113

Priority 61/109,708 30.10.08 US; 61/102,807 03.10.08 US

Filing date 2 October 2009

Wipo publication date 8 April 2010

International Classifications

A01N 37/36 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids - containing at least one carboxylic group or a thio-analogue, or a derivative thereof, and a singly bound oxygen or sulfur atom attached to the same carbon skeleton, this oxygen or sulfur atom not being a member of a carboxylic group or of a thio-analogue, or of a derivative thereof, e.g. hydroxy-carboxylic acids

Event Publications

28 April 2011 PCT application entered the National Phase

  PCT publication WO2010/040113 Priority application(s): WO2010/040113

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009298150-Compositions, kits and methods for the diagnosis, prognosis, and monitoring of cancer using GOLPH3

2009298131-CD86 antagonist multi-target binding proteins